5-({[bis(2-chloroethyl)amino][(1-methyl-2-nitro-1H-imidazol-5-yl)methoxy]phosphoryl}amino)-N-benzyl-N-ethyl-N-methylpentane-1-aminium iodide

ID: ALA4278857

Chembl Id: CHEMBL4278857

PubChem CID: 145982310

Max Phase: Preclinical

Molecular Formula: C24H40Cl2IN6O4P

Molecular Weight: 578.50

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[N+](C)(CCCCCNP(=O)(OCc1cnc([N+](=O)[O-])n1C)N(CCCl)CCCl)Cc1ccccc1.[I-]

Standard InChI:  InChI=1S/C24H40Cl2N6O4P.HI/c1-4-32(3,20-22-11-7-5-8-12-22)18-10-6-9-15-28-37(35,30(16-13-25)17-14-26)36-21-23-19-27-24(29(23)2)31(33)34;/h5,7-8,11-12,19H,4,6,9-10,13-18,20-21H2,1-3H3,(H,28,35);1H/q+1;/p-1

Standard InChI Key:  ZZOQSFSVPFONQM-UHFFFAOYSA-M

Associated Targets(Human)

H-EMC-SS (104 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ACAN Aggrecan core protein (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 578.50Molecular Weight (Monoisotopic): 577.2220AlogP: 5.16#Rotatable Bonds: 19
Polar Surface Area: 102.53Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.86CX Basic pKa: CX LogP: -0.46CX LogD: -0.46
Aromatic Rings: 2Heavy Atoms: 37QED Weighted: 0.06Np Likeness Score: -0.22

References

1. Ghedira D, Voissière A, Peyrode C, Kraiem J, Gerard Y, Maubert E, Vivier M, Miot-Noirault E, Chezal JM, Farhat F, Weber V..  (2018)  Structure-activity relationship study of hypoxia-activated prodrugs for proteoglycan-targeted chemotherapy in chondrosarcoma.,  158  [PMID:30199705] [10.1016/j.ejmech.2018.08.060]

Source